Our Next Event:
The goal of this CME program is to learn more about current trends, management techniques, recent innovations, and research to treat a full range of liver conditions, including Fatty Liver/NASH, Hepatocellular Carcinoma, Cholestatic Diseases, and Liver Transplantation. The American Association for the Study of Liver Diseases (AASLD) is the leading organization of scientists and healthcare professionals committed to preventing and curing liver disease. The AASLD fosters research that leads to improved treatment options for millions of liver disease patients. They advance the science and practice of hepatology through educational conferences, training programs, professional publications, and partnerships with government agencies and sister societies. Each November, the AASLD holds the Annual Liver Meeting to provide access and education to groundbreaking science, the exchange of ideas with leading clinicians and researchers, and network with peers.
*** Industry partners must have an exhibit or sponsorship to participate in the Community Liver Alliance programs and events.
Your support allows the Community Liver Alliance to continue to provide education, resources and support to the liver community we all serve.
For more information on ways to support and collaborate with the Community Liver Alliance, please contact Suzanna Masartis at Suzanna@communityliveralliance.org or 412-400-9343.
Global Awareness. Local Impact.
CLA's mission is to promote disease awareness, prevention, education, advocacy, and research. Headquartered in Pittsburgh and with offices in Milwaukee, the Community Liver Alliance has grown to have a national presence while still holding true to a mission to invest in local communities and give voice to patients and providers.
News & Information
There is 80 to 100 million people in the USA that have Fatty Liver Disease and most do not even know they have it. Liver Disease does not discriminate. It affects any age, social economics and race. Liver cancer incidence rates have more than tripled since 1980, while the death rates have more than doubled during this time.
Ensure funding for COVID-19 and liver disease public health programs, research, vaccine dissemination; ensure that people living with liver disease are not disproportionately impacted and do not experience unnecessary or discriminatory health care or treatment disruptions.
Address inequities in the care of people impacted by liver disease, especially the excess incidence rate of liver cancer in black men in America.
Advance the U.S. NASH Action Plan, and ensure patients with liver disease perspectives are represented in relevant legislative packages: COVID-19, diabetes, and obesity.
Work with regulators to establish logical pathways to consistently approve therapies for liver diseases, particularly rare liver diseases.
Advocate for funding that ensures meaningful growth of vital liver disease research and the improving of liver health.
Urgently respond to the inequities that impact organ transplantation; modernize the U.S. Organ Donation system, improve care for transplant patients, and increase the number of available organs.
Increase support for hepatitis programs and raise awareness of viral hepatitis; advocate for the elimination of viral hepatitis .
Advance health care policies that reflect each person’s unique needs and drive access to personalized, patient-centric care.
Support policy solutions that curb patients’ health care expenses; advocate for the smoothing and capping of out-of-pocket costs in Medicare Part D.
Upcoming Program & Events
Register Now: https://cvent.me/EZ31zo Program Overview The goal of the CME program is to learn more about current trends, management techniques, recent innovations, and research to treat a full range of […]
The 2022 Pediatric Liver Conference Register Now: https://cvent.me/GNlOrX Registration deadline December 1st Are you a clinician or caregiver supporting a child with liver disease? Join us for a virtual conference as […]
Virtual Liver Update Series 2022-2023 Register now: https://cvent.me/A9dQv0 Course Director William Hutson, MD WVU Medicine Section Chief & Professor, Gastroenterology & Hepatology, Medicine Professor & Section Chief, Gastroenterology & […]
Deadline for Submission is November 10th! At the Carnegie Science Center PointView Hall This award will select recipients to be recognized for their outstanding accomplishments going above and beyond supporting […]